Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer
Junnan Xu(Wenzhou Medical University), Mingxi Jing(China Medical University)
Cited by 13
Related Papers
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
|Journal of Cellular Physiology|2019|115
Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer
|Frontiers in Cellular and Infection Microbiology|2022|31